Literature DB >> 2256183

Structure-activity relationships of K+ channel openers.

G Edwards1, A H Weston.   

Abstract

Seven groups of synthetic agent, distinguished by a combination of their chemical and pharmacological characteristics exert some or all of their effects by opening plasmalemmal K+ channels primarily in smooth muscle. Progress over the past two years now allows broad structure-activity relationships to be formulated within many of the individual groups of agent. Gillian Edwards and Arthur Weston review the historical basis of these discoveries and comment on the significance of new developments. They focus on the search for tissue and channel selectivity, two factors likely to be important for the successful clinical deployment of these substances as antihypertensive and bronchodilator agents.

Mesh:

Substances:

Year:  1990        PMID: 2256183     DOI: 10.1016/0165-6147(90)90149-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  33 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 2.  ATP-sensitive potassium channels and myocardial ischemia: why do they open?

Authors:  W A Coetzee
Journal:  Cardiovasc Drugs Ther       Date:  1992-06       Impact factor: 3.727

3.  Hormone-regulated K+ channels in follicle-enclosed oocytes are activated by vasorelaxing K+ channel openers and blocked by antidiabetic sulfonylureas.

Authors:  E Honoré; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

4.  Cyclosporin A does not possess K+ channel opening properties in smooth muscle.

Authors:  B D Edwards; F W Ballardie; M Miller; A H Weston
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

5.  Opening of glibenclamide-sensitive K+ channels in follicular cells promotes Xenopus oocyte maturation.

Authors:  F Wibrand; E Honoré; M Lazdunski
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

Review 6.  Pharmacology of the potassium channel openers.

Authors:  G Edwards; A H Weston
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

7.  Potassium channel agonists modify the local anaesthetic activity of bupivacaine in mice.

Authors:  M Gantenbein; L Attolini; B Bruguerolle
Journal:  Can J Anaesth       Date:  1996-08       Impact factor: 5.063

8.  Effects of the novel potassium channel opener, UR-8225, on contractile responses in rat isolated smooth muscle.

Authors:  F Perez-Vizcaino; O Casis; R Rodriguez; L A Gomez; J Garcia Rafanell; J Tamargo
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  Time-dependent fading of the activation of KATP channels, induced by aprikalim and nucleotides, in excised membrane patches from cardiac myocytes.

Authors:  D Thuringer; I Cavero; E Coraboeuf
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

10.  Effects of P1060 and aprikalim on whole-cell currents in rat portal vein; inhibition by glibenclamide and phentolamine.

Authors:  T Ibbotson; G Edwards; T Noack; A H Weston
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.